Miotens (Thiocolchicoside)

Thiocolchicoside, the active ingredient in Miotens, is a muscle relaxant presented as an injectable formulation for intramuscular use. It is employed to alleviate muscle spasm, musculoskeletal discomfort and back pain in adult patients requiring central muscle relaxation, and may be used as part of a comprehensive pain management program under physician guidance.

GNH USA supplies Miotens as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics across multiple markets.

Miotens, containing the muscle‑relaxing agent Thiocolchicoside, is indicated for several musculoskeletal conditions characterized by excessive skeletal muscle activity and associated pain.

- Muscle spasm: reduces involuntary muscle contractions, providing rapid relief from associated pain, stiffness, and functional limitation, thereby improving patient comfort and mobility. - Musculoskeletal pain: alleviates discomfort in joints, tendons and surrounding soft tissues by decreasing excessive muscle tone that contributes to heightened pain perception and movement restriction. - Back pain: improves lumbar mobility and reduces paraspinal muscle tension, aiding in the management of both acute and chronic back discomfort and supporting rehabilitation efforts.

Thiocolchicoside may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Dizziness: transient sensation of lightheadedness. - Nausea: occasional upset stomach. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Hepatotoxicity: elevated liver enzymes or liver injury. - Hematologic disorders: rare cases of blood dyscrasias such as leukopenia or thrombocytopenia.

When prescribing or administering Miotens, several precautions should be observed to ensure patient safety.

- Medical supervision: use only under the direction of a qualified healthcare professional. - Hypersensitivity: avoid in patients with known allergy to Thiocolchicoside or formulation excipients. - Hepatic impairment: exercise caution and consider dose adjustment in severe liver disease. - Sedation risk: monitor patients for excessive drowsiness, especially when combined with other CNS depressants. - Pregnancy and lactation: use only if the potential benefit outweighs the unknown risk to fetus or infant. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Thiocolchicoside can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent central muscle relaxants: additive muscle‑relaxant effect may cause profound weakness. - CNS depressants (e.g., benzodiazepines, opioids): increased sedation and respiratory depression risk. - Known glycine‑receptor antagonists: may potentiate pharmacologic effects and toxicity.

Moderate Interactions (Monitor Closely): - CYP450 inhibitors or inducers: may alter Thiocolchicoside metabolism, requiring dose review. - Anticoagulants: potential for enhanced bleeding tendency. - Antihistamines: may increase sedation when combined.